An estimated 19.5 million HIV-infected people worldwide are now receiving antiretroviral therapy, and treatment programs have had substantial effects on the rate of new infections. But the emergence of HIV drug resistance is a very real threat to these gains.
No takes yet. Share an insight, caveat, or question.
Beyrer et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: